BCL2 and nonpapillary renal cell carcinoma: We found that ccRCC patients who had high LTB4R expressions also had higher expressions of BCL2 (Figure 7B, p < 0.05) and CDK4 levels (Figure 7F, p < 0.05) compared with ccRCC patients who had low LTB4R expressions.